Search

Your search keyword '"Rancati T"' showing total 968 results

Search Constraints

Start Over You searched for: Author "Rancati T" Remove constraint Author: "Rancati T"
968 results on '"Rancati T"'

Search Results

51. Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvement

52. High-Performance Cellular Radiosensitivity Assay Combined to a Polygenic Score to Predict Late Post Radiotherapy Overreaction in Cancer Prostate Patients: A Proof of Concept

53. Prostate Cancer Patients with a High Polygenic Risk of Rheumatoid Arthritis have Increased Radiotherapy Toxicity

54. Genome wide association study of long-term patient-reported outcomes following radiotherapy for breast cancer – results from the REQUITE cohort study

55. OC-0457 Modeling outcome after salvage post-prostatectomy radiotherapy: impact of pelvic nodes irradiation

56. PD-0414 Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer

57. MO-0804 Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer

58. PD-0163 Feasibility of Image-Based Data Mining in Breast Radiotherapy

59. PD-0161 Single-patient microbiota & inflammation profiles modulate dose-response curves for acute toxicity

60. PD-0174 Atlas-based auto-contouring of breast tissue in young female lymphoma patients

61. MO-0557 Estimates of α/β ratios for individual late urinary toxicity endpoints: analysis of a cohort trial

62. MO-0801 Machine learning based models of radiotherapy-induced skin induration for breast cancer patients

63. MO-0386 Treatment time and circadian genotype interact to alter the severity of radiotherapy side-effects

64. PO-1509 Proton therapy for nasopharyngeal cancer: dosimetric and NTCP analysis supporting clinical decision

66. PD-0733 Parameters influencing inter-Institute variability in KB plan prediction models for whole breast RT

67. PO-1595 Automated stability study on mpMRI prostate radiomics features to variations in segmentation

68. PD-0415 Pelvic RT in prostate cancer: late intestinal toxicity is modulated by severity of acute symptoms

69. MO-0381 Saliva microbiota and inflammation markers predict acute toxicity after RT for head-and-neck cancer

70. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

72. Dose-volume effect for acute patient-reported intestinal toxicity from whole pelvis radiotherapy: an Italian multicentric study

78. PD-0784 Predicting toxicity after RT for head and neck cancer: combining dosimetry with a biomarker

79. PD-0769 Patient-reported acute intestinal toxicity and impact on patient QoL after WPRT for prostate cancer

80. PD-0766 Impact of treatment and clinical factors on worsening of functional scales after prostate cancer RT

83. PH-0108 New dose-volume constraints for patient-reported acute bowel toxicity symptoms in whole pelvis IMRT

84. PO-1363 Prediction of urinary toxicity after prostate cancer RT: long term evaluation

85. PH-0385 Modulations of salivary microbiota during radiotherapy for head and neck cancer

86. PO-1342 Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer

87. PO-1345 Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer

88. PD-0767 Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer

89. PD-0782 Predicting bRFS after salvage post-prostatectomy RT with a “one-size-fits-all” TCP-based formula

90. PD-0925 An European cross-cultural analysis of worsening of functional scales in prostate cancer patients after RT

92. PO-1917 Circadian rhythm effects on radiotherapy toxicity

93. PH-0656 Prediction of toxicity after prostate cancer RT: the value of a SNP-interaction polygenic risk score

Catalog

Books, media, physical & digital resources